Biomedical subjects

Claus D Claussen

Publications and source records attributed to Claus D Claussen.

At least 127 records · Page 7Linked to original sources

PubMed2002

Flufenamic acid: growth modulating effects on human aortic smooth muscle cells in vitro.

PURPOSE: The aim of the study was to examine the effects of flufenamic acid on proliferation, clonogenic activity, migratory ability, cell-cycle distribution, and p44/42-mitogen-activated protein kinase (MAPK) expression on serum-stimulated human aortic smooth muscle cells (haSMCs) in vitro. MATERIALS AND METHODS: HaSMCs were treated with flufenamic acid in three different doses (40 micromol/L, 200 micromol/L, 400 micromol/L) for 4 days, and then flufenamic-acid-free culture medium was supplemented every 4 days until day 20 after initial treatment. The growth kinetics were assessed. Cell-cycle analysis was performed by flow cytometry. The clonogenic activity was evaluated with use of colony formation assays. The migratory ability was investigated by stimulation with platelet derived growth factor (PDGF-BB) in 24 well plates with 8-microm pore membrane inserts. The p44/42 MAPK was detected by Western blot technique. RESULTS: Flufenamic acid inhibited the proliferation (400 micromol/L treatment over 4 d; 179,700 +/- 49,800 vs 747,900 +/- 144,000; P <.001), clonogenic activity (400 micromol/L treatment over 4 d; 1 +/- 0.3 vs 50 +/- 1.4; P <.001) and migratory ability (400 micromol/L treatment over 4 d; 8 cells +/- 2 vs 48 cells +/- 15; P <.001) of haSMCs in a dose-dependent manner. Cell-cycle analysis revealed a G2/M-phase block (400 micromol/L treatment over 4 d; 28.9 +/- 1.5 vs 9.5 +/- 3.2; P <.001). The expression of p44/42 MAPK was reduced for a treatment with 400 micromol/L flufenamic acid (controls, 427 BLU +/- 0.305 vs treatment group, 190 BLU +/- 106; P <.05) CONCLUSION: Flufenamic acid inhibits the proliferation and migration of haSMCs. Further experiments with animal models concerning stenosis and restenosis are necessary to evaluate the potential of this promising drug.

Anti-Inflammatory Agents, Non-Steroidal↗

PubMed2002

Thrombogenicity of various endovascular stent types: an in vitro evaluation.

PURPOSE: The aim of this study was to evaluate the thrombogenicity of different peripheral stent types in a standardized in vitro model with fresh human whole blood. MATERIALS AND METHODS: Different stents (N = 77; n = 7 of each of 11 types) were implanted in polyvinyl chloride tubing loops and filled with donor blood samples. After 120 minutes of blood circulation, the thrombin-antithrombin III complex (TAT) levels, beta-thromboglobulin (beta-TG) levels, and platelet counts were assessed. RESULTS: After 2 hours, significant differences were seen. TAT values (+/- SD) with the investigated stents were 31 micro g/mL +/- 20 (control, no stent), 328 micro g/mL +/- 206 (Saxx stent, peripheral medium CrNi31 L), 651 micro g/mL +/- 760 (Palmaz Corinthian Stent, 316 L stainless steel, electropolished), 1,609 micro g/mL +/- 1,264 (Palmaz Corinthian Stent, 316 L stainless steel, not electropolished), 810 micro g/mL +/- 578 (Palmaz Schatz long medium stent), 569 micro g/mL +/- 347 (Smart Nitinol stent), 1,037 micro g/mL +/- 577 (Megalink peripheral stent), 543 micro g/mL +/- 487 (peripheral stent, electropolished), 1,674 micro g/mL +/- 2,057 (peripheral stent, not electropolished), 3,128 micro g/mL +/- 1,812 (SelfX Nitinol stent, polished), 5,897 micro g/mL +/- 2,380 (SelfX Nitinol stent, unpolished), and 1,458 micro g/mL +/- 887 (bridge stent). The platelet count (x1,000/ micro L +/- SD) was 218 +/- 35 (control, no stent), 188 +/- 22 (Saxx stent), 187 +/- 20 (Palmaz Corinthian stent, electropolished), 135 +/- 37 (Palmaz Corinthian stent, not electropolished), 170 +/- 24 (Palmaz Schatz stent), 180 +/- 36 (Smart Nitinol stent), 159 +/- 26 (Megalink peripheral stent), 173 +/- 17 (peripheral stent, electropolished), 133 +/- 51 (peripheral stent, not electropolished), 123 +/- 37 (SelfX Nitinol stent, polished), 52 +/- 27 (SelfX Nitinol stent, unpolished), and 130 +/- 31 (bridge stent). CONCLUSION: This standardized study showed a wide range of platelet activation after stent implantation. Electropolishing clearly reduced the thrombogenicity of the stents.

Adult↗

PubMed2002

Diagnostic potential of targeted electrical impedance scanning in classifying suspicious breast lesions.

RATIONALE AND OBJECTIVE: To evaluate the potential of targeted electrical impedance scanning (EIS) for classifying suspicious breast lesions. METHODS: EIS was performed in full knowledge of mammographic findings and findings of clinical breast examination. One hundred seventeen patients with a total of 129 breast lesions were examined with EIS before breast biopsy (surgical excision or vacuum core biopsy). Diagnostic indexes of targeted EIS were calculated depending on major lesion characteristics. Capacitance and conductivity of all positive spots (S) and the surrounding normal breast tissue (NBT) were quantified using ROI measurements. The ratio S/NBT was calculated to compare true positive (n = 44) and false positive (n = 18) spots. RESULTS: With respect to histology, of the 129 lesions 71 were malignant and 58 lesions were benign. Overall sensitivity of targeted EIS was 62%, specificity 69%, PPV 71%, and NPV 60%. Sensitivity of EIS varied depending on the tumor size, which was between 48% (> 20 mm) and 71% (11-20 mm). Highest specificity (86%) was observed for large lesions (> 20 mm); however, the NPV was only 35% for lesions of that size. NPV was higher for nonpalpable lesions (74%) and clusters of microcalcifications (85.7%) compared with palpable lesions (39%) and solid lesions (44%). There was no statistical difference of S/NBT ratio neither for conductivity nor capacitance of true and false positive spots. Compared with true positive spots a trend of a higher conductivity ratio at 100 Hz and 200 Hz was seen for false positive spots. CONCLUSION: EIS showed mediocre overall diagnostic accuracy for classifying suspicious breast lesions. Quantitative analysis of positive EIS findings did not help to differentiate between false and true positive spots.

Biopsy↗

PubMed2002

Antiproliferative effects of the antiallergic agent azelastine on human aortic smooth-muscle cells: an in vitro study.

RATIONALE AND OBJECTIVES: The aim of the study was to examine the effects of azelastine on proliferation, clonogenic activity, cell-cycle, and migration of human aortic smooth-muscle cells (haSMCs) in vitro. METHODS: HaSMCs were treated for 4 days with azelastine (1 micromol/L, 25 micromol/L, 50 micromol/L). Half of the treated groups were incubated again with azelastine, the other half received azelastine-free medium every 4 days until day 20. The growth kinetics and clonogenic activity were assessed. The cell-cycle distribution was investigated by FACS -- analysis and the migratory ability was evaluated. RESULTS: Azelastine inhibited the proliferation and the clonogenic activity of haSMCs in a dose dependent manner. A G2/M-phase block was induced and the migratory ability was significantly impaired. CONCLUSION: Azelastine has the potential to inhibit the proliferation of haSMCs. If a sufficient dose can be applied either systemically or locally it could be a valuable substance to prevent restenosis.

Anti-Allergic Agents↗

PubMed2002

Endothelin A receptor antagonist LU 135252 inhibits hypercholesterolemia-induced, but not deendothelialization-induced, atherosclerosis in rabbit arteries.

RATIONALE AND OBJECTIVES: The purpose of the study was to test the capability of the endothelin A receptor antagonist LU 135252 to reduce neointimal formation in rabbits after balloon denudation with and without the presence of hypercholesterolemia. METHODS: Twenty-eight male New Zealand White rabbits underwent balloon denudation of the infrarenal aorta. The animals were randomly assigned to 1 of the 4 groups. After balloon denudation, group 1 (n = 6) and 2 (n = 7) received a standard diet, and group 3 (n = 8) and 4 (n = 7) were fed a 0.5% cholesterol diet. All interventional procedures were performed while the rabbits were under general anesthesia. One week prior to intervention treatment with LU 135252 was started in group 2 and 4. After 6 weeks the animals were killed for morphometric and histological analysis. RESULTS: Rabbits in all treatment groups developed neointimal hyperplasia. By additional systemic treatment with LU 135252, the mean neointima to media ratio was significantly reduced only in the hypercholesterolemic animals of group 4 (neointimal to media ratio area of group 3 vs group 4: 2.07 +/- 0.62 vs 1.41 +/- 0.45, P < 0.05). ET receptor blockade in group 2 and 4 did not have an effect on plasma levels of cholesterol, very low-density lipoprotein-, high-density lipoprotein-, and low-density lipoprotein-cholesterol. CONCLUSION: LU 135252 was efficient in reducing lipid induced atherosclerotic changes but was ineffective in inhibiting restenosis induced by balloon denudation.

Animals↗

PubMed2002

Stent struts and articulations: their impact on balloon-expandable stents' hoop strength, pushability, and radiopacity in an experimental setting.

OBJECTIVES AND RATIONALE: To evaluate the hoop strength, the pushability, and the radiopacity of endovascular stents depending on their design. MATERIAL AND METHODS: The Palmaz Medium (rectangular stent struts, no articulation = RE-NA), the Palmaz-Schatz Long-Medium (rectangular stent struts, central articulations = RE-CA), and the 39 mm and 29 mm version of the Palmaz Corinthian Stent (arch-like stent struts, omega hinges = AR-OH 1 and AR-OH 2) were included in the study. Hoop strength, pushability, and radiopacity were assessed in-vitro. A radiopacity score (RS)-ranging from 0 = invisible, 1 = poor, 2 = average, 3 = good, and 4 = very good-was used. RESULTS: Mass adjusted hoop strength was nearly the same for the AR-OH 1 and the AR-OH 2 (AR-OH 1: 159.2 N/g*cm; AR-OH 2: 156.5 N/g*cm). Their hoop strengths per unit mass significantly exceeded that of a RE-NA (125 N/g*cm) and that of a RE-CA (75.3 N/g*cm). The most pushable stent was the AR-OH 2 (0.54 1/N) followed by the AR-OH 1 (0.47 1/N) and the RE-CA (0.169 1/N). Because of multiple stent dislocations, the RE-NA was considered nonflexible. At spotfilm mode the RE-NA was the most visible stent (RS 3.5) followed by the AR-OH 1 (RS 3.25), the RE-CA (RS 3.12), and the AR-OH 2 (RS 1.9). At continuous fluoroscopy the AR-OH 1 (RS 1.8) was better than the RE-CA (RS 1.125), the RE-NA (RS 1.0), and the AR-OH 2 (RS 0.6). At 7.5 pulses per second the RE-NA (RS 1.3) performed slightly better than the AR-OH 1 (RS 1.25), and clearly better than the RE-CA (RS 0.8), and the AR-OH 2 (RS 0.3). CONCLUSION: Overall, the ideal stent-having high hoop strength, a low profile, a good pushability, and a good radiopacity-still does not exist. However, by changing strut design (from rectangular to arch-like struts) and by inserting articulations, hoop strength and pushability can be improved without reducing radiopacity.

Angioplasty, Balloon↗

PubMed2002

Reproducibility and accuracy of coronary calcium measurements with multi-detector row versus electron-beam CT.

PURPOSE: To methodically evaluate the reproducibility and accuracy of coronary arterial calcification measurements by using spiral multi-detector row and electron-beam computed tomography (CT) with a beating heart phantom. MATERIALS AND METHODS: A phantom was built to mimic a beating heart with coronary arteries and calcified plaques. The simulated vessels moved in a pattern similar to that of a beating heart. The phantom operated at a variety of pulse rates (0-140 beats per minute). The phantom was repeatedly scanned in various positions by using various protocols with electron-beam and multi-detector row CT scanners to assess interexamination variability. Statistical analysis was performed to determine significant differences in interexamination variability for various acquisition protocols. RESULTS: Electrocardiographically (EKG) gated volume coverage with spiral multi-detector row CT (2.5-mm collimation) and overlapping image reconstruction (1-mm increment) was found to significantly improve the reliability of coronary arterial calcium quantification, especially for small plaques (P <.05). Mean interexamination variability was reduced from 35% +/- 6 (SD) (Agatston score, standard electron-beam CT) to 4% +/- 2 (P <.05) (volumetric score, spiral EKG-gated multi-detector row CT). CONCLUSION: By coupling retrospective gating with nearly isotropic volumetric imaging data, spiral multi-detector row CT provides better input data for quantification of coronary arterial calcium volume. Multi-detector row CT allows precise and repeated measurement of coronary arterial calcification, with low interexamination variability.

Calcinosis↗

PubMed2002

Economic value of thrombolysis with adjunctive abciximab in patients with subacute peripheral arterial occlusion.

BACKGROUND AND OBJECTIVE: Glycoprotein (GP) IIb/IIIa receptor inhibitors enhance thrombolysis in patients with acute coronary syndromes. This analysis evaluates the economic impact of abciximab, a GP IIb/IIIa inhibitor, as an adjunct to urokinase in peripheral artery occlusions of less than 6 weeks duration. STUDY DESIGN: A post-hoc economic analysis was performed using clinical data and inpatient resource utilisation derived from the prospective comparative phase II Platelet Receptor Antibodies in Order to Manage Peripheral Artery Thrombosis (PROMPT) pilot study. Study endpoints were amputation-free survival and survival without open surgery or major amputation after 90 days, and the rate of major complications at 30 days. PERSPECTIVE: Third-party payer and the societal perspective. PATIENTS AND METHODS: Seventy patients with lower extremity thrombi were randomised (2 : 5 ratio) to urokinase plus placebo or to urokinase plus abciximab. Economically relevant data were retrospectively derived from the clinical study database from a specific evaluation of patient records and from expert opinion. RESULTS: From the viewpoint of the society, average total per-patient direct and indirect costs accruing over 3 months were more favourable for treatment with abciximab plus urokinase than for urokinase alone [9723 euros (EUR) vs EUR10 322; 2000 values], despite higher initial hospitalisation costs of the combination therapy. Abciximab plus urokinase was the dominant strategy at 3 months due to a clinically higher rate of survival without amputation or bypass surgery coupled with a lower average per-patient cost. From the perspective of the third-party payer, treatment with abciximab plus urokinase was economically also superior to urokinase alone (EUR8773 vs EUR9663). CONCLUSIONS: Based on the preliminary findings of the PROMPT trial, the use of abciximab as an adjunct to urokinase in patients with subacute peripheral artery occlusions may be the favourable strategy compared with urokinase alone, in terms of clinical and economic outcomes. Further trials are needed to confirm these clinical and economic findings. The preliminary clinical benefits experienced by patients treated with abciximab plus urokinase in the PROMPT trial translated into cost savings in terms of reduced direct medical costs at 3 months. These cost savings more than offset the cost of abciximab. The use of abciximab as an adjunct to urokinase in patients with subacute peripheral artery occlusions may be the favourable strategy compared with urokinase-alone in terms of clinical and economic outcomes, but further trials are needed to confirm the these clinical and economic findings.

Abciximab↗

PubMed2002

MR imaging-detected breast lesions: histopathologic correlation of lesion characteristics and signal intensity data.

OBJECTIVE: The aim of our study was to differentiate benign from malignant breast lesions that had been detected exclusively on MR imaging by analyzing qualitative and quantitative lesion characteristics. MATERIALS AND METHODS: We performed 51 MR imaging-guided breast interventions (41 preoperative lesion localizations and 10 large-core needle biopsies) in 45 patients with exclusively MR imaging-detected lesions. All patients had previously undergone diagnostic dynamic contrast-enhanced MR imaging of the breast with a double breast coil at 1.0 T (n = 36) or 1.5 T (n = 15). The diagnostic MR images were evaluated on a workstation. Lesion morphology (size, shape, margin type, enhancement pattern), signal intensity parameters (time to peak enhancement, maximum slope of enhancement curve, washout, relative water content), and scores analogous to the Breast Imaging Reporting and Data System (BI-RADS) categories were correlated with histology. RESULTS: Histology revealed malignancy in 37.3% (19/51) of the lesions. The positive predictive value for malignancy of exclusively MR imaging-detectable lesions increased as the analogous BI-RADS category increased. Late inhomogeneous contrast enhancement was the only morphologic criterion that was statistically significantly correlated with malignancy. Malignant and benign lesions did not differ significantly in any of the quantitatively evaluated signal intensity parameters. Carcinomas showed a tendency toward faster and stronger enhancement and stronger washout. CONCLUSION: The classification of exclusively MR imaging-detectable breast lesions according to a combination of morphologic and perfusion parameters including the late enhancement pattern helps identify the lesions for which interventional MR imaging is required. Quantitative signal intensity data alone do not suffice.

Adult↗

PubMed2001

Multidetector helical CT of the liver for tumor detection and characterization.

Multidetector-row CT (MDCT) scanners have been recently introduced into clinical practice. Major attributes that are improved are the z-axis coverage speed and the longitudinal resolution. These improvements translate into rapid hepatic imaging and allow new imaging protocols. Thin sections can now be used on a routine basis in single-breath-hold technique. This results in improved lesion detection and the nearly isotropic image acquisition provides high-resolution multiplanar reformations. Furthermore, the ability to scan through the entire liver in 10 s or less allows acquisition of two separate sets of CT images of the liver within the time generally regarded as the hepatic arterial dominant phase in monoslice CT; thus, MDCT may demonstrate three clear separate distinct hepatic circulatory phases with a triple-pass technique. Multidetector-row CT with the improvements in morphological and functional information compared with single-slice CT enables a comprehensive approach to hepatic imaging within a single examination.

Carcinoma, Hepatocellular↗

PubMed2001

MR-guided lumbar sympathicolysis.

The aim of this study was to demonstrate the feasibility of MR-guided lumbar sympathicolysis (LSL) in a non-selected patient population. One hundred one MR-guided LSL procedures were performed in 89 patients according to Haaga's technique using a horizontally open clinical MR system (0.2 T) and non-ferromagnetic 20-G cannulas (neurolysis, n=93; blockade, n=8). Only gradient-recalled sequences in either single or multislice mode [fast imaging with steady-state precession (FISP) and fast low-angle shot] were applied for anatomical survey and needle guiding. Bupivacaine injection was monitored with MR fluoroscopically. Fluid distribution was subsequently documented in a CT scan in 65 patients. Ninety-one LSL procedures could be successfully completed. Ten patients were not treated using MR due to patient inconvenience, severe motion artifacts ( n=4 each), excessive spondylophytes, and retroperitoneal hematoma ( n=1 each). One case of ureteral necrosis occurred. Motion artifacts were rated less severe in single-slice FISP sequences and in obese patients. An average of 3.48 sequence measurements were required for definitive needle placement. Average table time was 32.3 min. An MR-guided LSL is feasible and can be performed with acceptable safety and time effort. It can be recommended for repeated sympathetic blockades in younger patients to avoid cumulative irradiation associated with CT guidance.

Adult↗

PubMedDate not supplied

Frequent embolization in peripheral angioplasty: detection with an embolism protection device (AngioGuard) and electron microscopy.

PURPOSE: To evaluate the deliverability and protection capabilities of an embolism protection filter in angioplasty of peripheral arteries. METHODS: The Angioguard emboli capture guidewire system was applied in 11 patients with femoropopliteal lesions (6 stenoses, 3 occlusions, 2 controls). Data on lesion crossing, flow deceleration and macroembolization were recorded. Filter membranes were evaluated with scanning electron microscopy (SEM). RESULTS: System delivery was successful in all patients. Primary lesion crossing was feasible in four of six stenoses; predilatation was required in two of six. Marked flow deceleration was recorded in six patients. Emboli next to the filter were detected in each patient with concentric plaques, but could not reliably be removed with the filter. Downstream macroembolization was also present in all patients with concentric stenoses, but in none with chronic occlusion. None of the patients had clinical signs of ischemia. SEM analysis demonstrated only small particles on control group filters and non-obliterating fibrinous conglomerates on filters used in chronic occlusion. Substantial obliteration was seen on several filters used in stenotic lesions. CONCLUSION: Microembolization of fibrin aggregates is a common incident in balloon angioplasty of femoropopliteal stenoses. Macroembolization occurred more frequently than previously reported. The use of embolism protection filters aided in the detection but not in the removal of larger emboli.

Aged↗

PubMedDate not supplied

Reduction of intimal hyperplasia with Re-188-labeled stents in a rabbit model at 7 and 26 weeks: an experimental study.

The aim of this study was to analyze the feasibility of (188)Re-labeled stents to reduce neointimal formation in a rabbit atherosclerosis model and to test the long-term effects at 7 and 26 weeks. Fifty-nine male New Zealand White rabbits were fed a 0.5% cholesterol diet for 4 weeks before balloon angioplasty and insertion of Palmaz stents in the infrarenal aorta. The animals were sacrificed 7 and 26 weeks after stent implantation. Control stents were compared with (188)Re stents: (dose 1) 11.3 +/- 1.8 MBq; (dose 2) 37.3 +/- 4.2 MBq, and (dose 3) 80.1 +/- 7.8 MBq. Each activity group consisted of a short-term (7 weeks) and a long-term group (26 weeks), resulting in a total of eight study groups. No thrombotic occlusion was observed. The neointimal formation in the control group was 2.11 [95% confidence interval (CI): 0.68--6.52] mm(2) at 7 weeks and 2.10 (0.62--7.11) at 26 weeks. In the treatment groups, neointima reduction was detectable at 7 weeks [dose 1: 0.33 (0.09--1.22) mm(2); dose 2: 0.17 (0.05--0.57) mm(2); dose 3: 0.03 (0.01--0.13) mm(2)]. After 26 weeks, a catch-up of neointimal formation in the radioactive groups was most obvious in the low-dose group [dose 1: 0.80 (0.28--2.29) mm(2); dose 2: 0.18([0.06--0.52) mm(2); dose 3: 0.50 (0.17--1.42) mm(2)]. Compared to the long-term control group, neointimal reduction was still >60%. No induction of neointimal formation was observed at the edges of the stents. Radiation resulted in delayed re-endothelialization. (188)Re stents were capable to reduce intimal hyperplasia and did not cause thrombosis. The edge effect, which was the major limitation of (32)P stents, was not observed in (188)Re stents.

Animals↗

PubMedDate not supplied

Influence of NaCl concentrations on coagulation, temperature, and electrical conductivity using a perfusion radiofrequency ablation system: an ex vivo experimental study.

PURPOSE: To determine, by means of an ex vivo study, the effect of different NaCl concentrations on the extent of coagulation obtained during radiofrequency (RF) ablation performed using a digitally controlled perfusion device. METHOD: Twenty-eight RF ablations were performed with 40 W for 10 min using continuous NaCl infusion in fresh excised bovine liver. For perfusion, NaCl concentrations ranging from 0 (demineralized water) to 25% were used. Temperature, the amount of energy, and the dimensions of thermal-induced white coagulation were assessed for each ablation. These parameters were compared using the nonparametric Mann-Whitney test. Correlations were calculated according to the Spearman test. RESULTS: RF ablation performed with 0.9% to 25% concentrations of NaCl produced a mean volume of coagulation of 30.7 +/- 3.8 cm(3), with a mean short-axis diameter of 3.6 +/- 0.2 cm. The mean amount of energy was 21,895 +/- 1,674 W and the mean temperature was 85.4 +/- 12.8 degrees C. Volume of coagulation, short-axis diameter, and amount of energy did not differ significantly among NaCl concentrations (p > 0.5). A correlation was found between the NaCl concentration and the short-axis diameter of coagulation (r = 0.64) and between the NaCl concentration and the mean temperature (r = 0.67), but not between the NaCl concentration and volume of coagulation. CONCLUSION: In an ex vivo model, continuous perfusion with high NaCl concentrations does not significantly improve the volume of thermal-induced coagulation. This may be because the use of a low-power generator cannot sufficiently exploit the potential advantage of better tissue conductivity provided by NaCl perfusion.

Animals↗

PubMedDate not supplied

Coronary vessel visualization using true 16-row multi-slice computed tomography technology.

BACKGROUND: Multi-slice computed tomography (MSCT) scanners with retrospective ECG-gating permit visualization of the coronary arteries. Limited spatial and temporal resolution as well as breathing artefacts due to the scan time can cause poor distal vessel segment and side branch visualization. The latest MSCT generation with true 16-detector slices (Sensation 16), Siemens, Forchheim, Germany) provides furthermore improved temporal and spatial resolution, as well as significantly reduced scan time. To assess, whether this technical improvement has also an impact on image quality we conducted the following study. METHODS AND MATERIAL: Sixty-two consecutive patients (33 male, 29 female, mean age 63+/-8 [47-79] years, heart rate after beta-blockade 63+/-7 [45-86] bpm) with suspicion of coronary artery disease (CAD) were examined by cardiac MSCT. Parameter settings were: 0.75 mm collimation, 2.8mm table feed/rotation, caudocranial scan direction, 80 cc contrast media biphasic injection protocol, gantry rotation time 375 ms, temporal resolution 188 ms). Thirteen coronary segments (sgts) were evaluated in each patient (total number: 806 sgts). Image quality of each segment was determined as: excellent--free of motion artefacts, good--mild motion artefacts, relevant artefacts--still diagnostic value, severe calcification and insufficient image quality--not visualized segment. RESULTS: 301/806 (37%) sgts showed excellent and 294/806 (36%) sgts good image quality. Relevant artefacts were seen in 107/806 (13%) sgts, calcifications in 41/806 (5%) sgts. 63/806 (8%) sgts could not be visualized (34 of them (54%) either segment 9 or 10). Diagnostic image quality was achieved in 702/806 (87%) sgts. CONCLUSIONS: Due to true 16-slice technology and faster gantry rotation time MSCT image quality could be improved and allows a visualization of the entire coronary tree. Larger, randomized, catheter-controlled studies have to be conducted to determine, whether this improved visualization also translates into better diagnostic accuracy.

Aged↗

PubMedDate not supplied

Influence of heart rate on vessel visibility in noninvasive coronary angiography using new multislice computed tomography: experience in 94 patients.

OBJECTIVES: Initial reports indicate that coronary artery lesions might be visualized with high sensitivity and specificity by the use of recently introduced multislice computed tomography (MSCT). Current CT technology offers a temporal resolution of 250 ms. In case of heart rates (HRs) >65 beats/min (bpm), however, the reconstruction software switches from a single-phase algorithm (using data from one heart cycle only) to a biphase algorithm using image data of two consecutive heart cycles, improving temporal resolution to down to 125 ms. Thus, it was the aim of the present study to evaluate the influence of the patients' (pts) HR on image quality expressed by vessel segment visibility. METHODS AND RESULTS: MSCT scans (Somatom VZ) were performed in 94 pts. Ten coronary segments were analyzed in each patient with regard to image quality (RCA: segments [sgts] 1-4, LMS: sgt 5, LAD: sgts 5-8, LCX: sgts 11, 12). A total of 697 of 940 (74.1%) sgts were accurately visualizable (RCA: 244/376 [64.9%], LMS: 94/94 [100%], LAD: 232/283 (82.3%), LCX: 146/188 [77.7%]). Beta-blocker therapy had a significant influence on mean HR (65 pts on beta-blocker, HR 65.1+/-10.7 bpm vs. 29 pts, HR 71.6+/-12.2 bpm, P=.01). A significant inverse correlation between HR and segmental visibility was found (r=-.48, P<.0001), with best visibility in pts with lower HRs (n=14 pts with 10 analyzable sgts, HR 60+/-10.1 vs. n=8 pts with 4 analyzable sgts, HR 79.9+/-6.9, P<.0001). CONCLUSIONS: Our results indicate that vessel visibility is highly dependent on the pts HR. Best vessel visibility was found in pts with HR <65 bpm with single-phase image reconstruction. Thus, it appears to be advisable to evaluate, and if needed, to lower the pts HRs before undergoing MSCT coronary angiography in order to achieve best image quality.

Adult↗

PubMedDate not supplied

Reliability of differentiating human coronary plaque morphology using contrast-enhanced multislice spiral computed tomography: a comparison with histology.

BACKGROUND: Initial clinical results indicate that multislice spiral computed tomography (MDCT) might be useful for the noninvasive characterization of human coronary plaque morphology by determining tissue density within the lesions. This seems to be of clinical relevance, because coronary artery disease might be detected at an early stage before calcifications occur and noncalcified plaques that may be more likely to rupture could also be visualized noninvasively. The aim of the present study was to evaluate the reliability of contrast-enhanced MDCT in differentiating human atherosclerotic coronary plaque morphology by comparing it with the histopathologic gold standard. METHODS AND RESULTS: Twelve human hearts were scanned postmortem using an MDCT (Somatom Volume Zoom; Siemens, Forchheim, Germany) high-resolution computed tomography scanner to detect atherosclerotic coronary plaques. Density measurements were performed within detected plaque areas. The exact location of each plaque was marked at the surface of the heart to assure accurate histopathologic sectioning of these lesions. The plaques were classified according to a modified Stary classification. Seventeen plaques were identified by MDCT. Six plaques were histopathologically classified as lipid rich (Stary III/IV), 6 plaques as intermediate (Stary V), and 5 plaques as calcific (Stary VII). Lipid-rich plaques had a mean density on MDCT of 42 +/- 22 Hounsfield units (HU), intermediate plaques had a mean density of 70 +/- 21 HU, and calcific plaques had a mean density of 715 +/- 328 HU. ANOVA analysis revealed a significant difference in plaque density between the 3 groups (P < 0.0001). CONCLUSIONS: The comparison with histopathology confirms that tissue density as determined by contrast-enhanced MDCT might be used to differentiate atherosclerotic plaque morphology.

Analysis of Variance↗

PubMedDate not supplied

Right ventricle shape and contraction patterns and relation to magnetic resonance imaging findings.

OBJECTIVE: To analyze and to describe the shape and contraction of the normal right ventricle (RV) as visualized by magnetic resonance imaging (MRI). METHODS: Thirty normal volunteers were imaged using cine MRI in axial, short-axis, and long-axis planes. The shape and contraction of the RV were qualitatively evaluated. Quantitative evaluation of RV shape was performed by calculating the angle subtended between the planes of horizontal long-axis view (HLA) and axial view and the RV base-to-apex distance. Multiplanar reformation was used to visualize changes between corresponding views. RESULTS: The spectrum of major RV shape (wedge, box, and round) was more variable on axial images (17%, 43%, and 23%, respectively) than on HLA images (63%, 20%, and 0%, respectively). Focal outpouching of the RV free wall was more frequent on the axial view than on the HLA view. The subtended plane angle and base-to-apex distance showed statistically significant dependence indicative of an artificially foreshortened RV in the axial view with a direct influence on RV variations. CONCLUSIONS: With increasing subtended angles, variation of the normal RV appearance is substantially higher on axial views compared with HLA views.

Adult↗